Published in Transplant Direct on June 06, 2016
Activin B is a novel biomarker for chronic fatigue syndrome/myalgic encephalomyelitis (CFS/ME) diagnosis: a cross sectional study. J Transl Med (2017) 0.75
Activin Biology After Lung Transplantation. Transplant Direct (2017) 0.75
Kidney Injury Molecule-1 (KIM-1): a novel biomarker for human renal proximal tubule injury. Kidney Int (2002) 8.03
Ischemia and reperfusion--from mechanism to translation. Nat Med (2011) 6.64
Cellular pathophysiology of ischemic acute kidney injury. J Clin Invest (2011) 5.75
Treatment of acute renal failure. Kidney Int (1998) 4.75
Regulatory T cells suppress innate immunity in kidney ischemia-reperfusion injury. J Am Soc Nephrol (2009) 2.18
Activin A is a critical component of the inflammatory response, and its binding protein, follistatin, reduces mortality in endotoxemia. Proc Natl Acad Sci U S A (2007) 1.62
Structure of two human ovarian inhibins. Biochem Biophys Res Commun (1986) 1.57
The interaction between ischemia-reperfusion and immune responses in the kidney. J Mol Med (Berl) (2009) 1.49
Primary structure of the human follistatin precursor and its genomic organization. Proc Natl Acad Sci U S A (1988) 1.33
Roles of activin in tissue repair, fibrosis, and inflammatory disease. Cytokine Growth Factor Rev (2006) 1.30
The roles of activin A and its binding protein, follistatin, in inflammation and tissue repair. Mol Cell Endocrinol (2011) 1.23
Messengers without borders: mediators of systemic inflammatory response in AKI. J Am Soc Nephrol (2013) 1.14
Activin A and follistatin in systemic inflammation. Mol Cell Endocrinol (2004) 1.12
Serum activin A and follistatin concentrations during human pregnancy: a cross-sectional and longitudinal study. Hum Reprod (1999) 1.08
The regulation and functions of activin and follistatin in inflammation and immunity. Vitam Horm (2011) 1.08
Development and application of a two-site enzyme immunoassay for the determination of 'total' activin-A concentrations in serum and follicular fluid. J Endocrinol (1996) 1.07
Ischemic kidney injury and mechanisms of tissue repair. Wiley Interdiscip Rev Syst Biol Med (2010) 1.06
Activins are critical modulators of growth and survival. Mol Endocrinol (2003) 1.00
The activins and their binding protein, follistatin-Diagnostic and therapeutic targets in inflammatory disease and fibrosis. Cytokine Growth Factor Rev (2013) 0.99
Differential binding and neutralization of activins A and B by follistatin and follistatin like-3 (FSTL-3/FSRP/FLRG). Endocrinology (2003) 0.95
Beta A versus beta B: is it merely a matter of expression? Mol Cell Endocrinol (2004) 0.94
A new 'total' activin B enzyme-linked immunosorbent assay (ELISA): development and validation for human samples. Clin Endocrinol (Oxf) (2009) 0.93
Follistatin and its role as an activin-binding protein. J Med Invest (1997) 0.92
Serum activin A and B levels predict outcome in patients with acute respiratory failure: a prospective cohort study. Crit Care (2013) 0.92
Serum neutrophil gelatinase-associated lipocalin correlates with kidney function in renal allograft recipients. Clin Transplant (2009) 0.88
Acute regulation of activin A and its binding protein, follistatin, in serum and tissues following lipopolysaccharide treatment of adult male mice. Am J Physiol Regul Integr Comp Physiol (2012) 0.84
A two-site chemiluminescent assay for activin-free follistatin reveals that most follistatin circulating in men and normal cycling women is in an activin-bound state. J Clin Endocrinol Metab (1998) 0.83
Involvement of the activin-follistatin system in tubular regeneration after renal ischemia in rats. J Am Soc Nephrol (2001) 0.83
Regulation and actions of activin A and follistatin in myocardial ischaemia-reperfusion injury. Cytokine (2014) 0.80
Beneficial effects of follistatin in hepatic ischemia-reperfusion injuries in rats. Dig Dis Sci (2010) 0.78